2022 Volume 7 Issue 1 Pages 8-13
It has been reported that about half of the patients with intracranial cystic lesion have headache, but the usefulness of Kampo treatment is still unknown. In this study, we retrospectively examined 33 cases treated with Kampo at the Iyemasa Neurosurgical Clinic for 9 years from January 2011 to October 2019. Twenty–seven cases (81.8%) showed improvement of symptoms. Among them, the headache diminished within 3 days in 8 cases (29.6%), and 14 days in 19 cases (70.4%). The therapeutic effect was observed within and early. Kampo treatment, especially goreisan which is hydrous drug, for headache with intracranial cystic kesion may be useful.